Kathleen Tregoning - Net Worth and Insider Trading

Kathleen Tregoning Net Worth

The estimated net worth of Kathleen Tregoning is at least $337,919 dollars as of 2024-11-10. Kathleen Tregoning is the See Remarks of Cerevel Therapeutics Holdings Inc and owns about 7,516 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $337,919. Details can be seen in Kathleen Tregoning's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen Tregoning has not made any transactions after 2023-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kathleen Tregoning

To

Kathleen Tregoning Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathleen Tregoning owns 2 companies in total, including Spero Therapeutics Inc (SPRO) , and Cerevel Therapeutics Holdings Inc (CERE) .

Click here to see the complete history of Kathleen Tregoning’s form 4 insider trades.

Insider Ownership Summary of Kathleen Tregoning

Ticker Comapny Transaction Date Type of Owner
SPRO Spero Therapeutics Inc 2021-10-11 director
CERE Cerevel Therapeutics Holdings Inc 2023-12-20 See Remarks

Kathleen Tregoning Latest Holdings Summary

Kathleen Tregoning currently owns a total of 1 stock. Kathleen Tregoning owns 7,516 shares of Cerevel Therapeutics Holdings Inc (CERE) as of December 20, 2023, with a value of $337,919.

Latest Holdings of Kathleen Tregoning

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CERE Cerevel Therapeutics Holdings Inc 2023-12-20 7,516 44.96 337,919

Holding Weightings of Kathleen Tregoning


Kathleen Tregoning Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathleen Tregoning has made a total of 1 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 6,288 shares on December 20, 2023, which brought Kathleen Tregoning around $260,449.

Insider Trading History of Kathleen Tregoning

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathleen Tregoning Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kathleen Tregoning Ownership Network

Ownership Network List of Kathleen Tregoning

No Data

Ownership Network Relation of Kathleen Tregoning

Insider Network Chart

Kathleen Tregoning Owned Company Details

What does Spero Therapeutics Inc do?

Who are the key executives at Spero Therapeutics Inc?

Kathleen Tregoning is the director of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Development Officer Timothy Keutzer , director & See Remarks Ankit Mahadevia , and Chief Financial Officer Sath Shukla .

Spero Therapeutics Inc (SPRO) Insider Trades Summary

Over the past 18 months, Kathleen Tregoning made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 117,209 shares made by Sath Shukla , a net sale of 78,747 shares made by Ankit Mahadevia , and a net sale of 35,038 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 10,882 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 10,882 shares. During the past 18 months, 331,325 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 331,325 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spero Therapeutics Inc Insider Transactions

No Available Data

Kathleen Tregoning Mailing Address

Above is the net worth, insider trading, and ownership report for Kathleen Tregoning. You might contact Kathleen Tregoning via mailing address: C/o Cerevel Therapeutics Holdings, Inc., 131 Dartmouth Street Suite 502, Boston Ma 02116.